KL and cancer: The inhibition of the PI3K/Akt pathway using the inhibitor LY294002 diminished the enhanced cancer growth observed with Klotho knockdown. Furthermore, transfecting Klotho into SQ5 lung cancer cells demonstrated its ability to suppress the mesenchymal marker N-cadherin